Hexa Reports

Market Research Reports and Insightful Company Profiles

STD Diagnostics Industry Share and Size, Market Analysis,

Trends and Growth, End-use And Segment Forecasts To
2022

Global STD diagnostics market is expected to reach USD 200.9 billion by 2022 according to a new study
by Grand View Research Inc. The rising geriatric population base, increasing global incidence of various
STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving
forces for the STD diagnostics market growth over the forecast period.
Increasing number of people having multiple partners and low levels of infection awareness levels are
the major drivers fueling industrial growth. Increasing demand for rapid and accurate diagnostic tests
and presence of favorable government initiatives for STD testing in developing countries such as Brazil,
India, and China are further estimated to boost market growth.
Browse Detail Report With TOC @
http://www.hexareports.com/report/std-diagnostics-market-analysis/details
Further key findings from the study suggest:
Chlamydia testing accounted for over 34% of the market in 2014. Chlamydia testing for sexually active
women aged below 25 years is strictly recommended by the U.S Preventive Services Task Force (PSTF).

Hexa Reports
Market Research Reports and Insightful Company Profiles
Syphilis testing is estimated to witness lucrative growth over the forecast period. It is anticipated to
grow at a CAGR of 10% owing to increasing prevalence of syphilis infection globally.
On the basis of test location, laboratory testing held the largest market share of over 63% in 2014 owing
to the availability of cost effective diagnostic tests used for multiple STIs at a single location such as
public health labs. Point of care on the other hand is anticipated to be the fastest growing segment over
the forecast period owing to the owing to the introduction of CLIA waived tests.
Laboratory testing devices dominated the market in 2014 with revenue generation of over 67.0 billion.
Immunochromatographic assays were most preferred devices for STD diagnosis in laboratory with
revenue share of over 26%. Increasing technological advancements are estimated to enhance usage
rates of thermal cyclers over the forecast period.
Portable/bench top or rapid diagnostic kits are estimated to gain demand over the forecast period
owing to features such as user-friendliness, increasing awareness pertaining to self testing, and fast
results.
North America held the largest share of the STD diagnostics market with revenue generation of over 32
billion in 2014. Introduction of technologically advanced diagnostics techniques such as
immunochromatographic device by Chembio Diagnostics Systems Inc. is the major factor attributing for
its largest market share.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/98289
Asia Pacific region is estimated to witness significant growth over the forecast period owing to the
presence of high amount of target population, rising awareness levels for STIs, and increasing
government initiatives and rise in disposable income expenditure levels. Asia Pacific is expected to show
double digit CAGR growth over the forecast period.
Major companies of the STD diagnostics industry include Roche Holdings AG, Abbott Laboratories,
Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid
Inc., Alere Inc., DiaSorin, and Orasure
Licensing and partnership deal making activities in the molecular diagnostics sector are growing
significantly in terms of value. New entrants such as life science research groups, financial investors,
clinical laboratories, and medical technology players drive up the values.
Table Of Content
Chapter 1. Methodology and Scope
1.1. Research methodology

Hexa Reports
Market Research Reports and Insightful Company Profiles
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. STD diagnostics market - Industry Summary and Key Buying Criteria, 2012 - 2022
Chapter 3. STD Diagnostics Industry Outlook
3.1. STD diagnostics market segmentation
3.2. STD diagnostics market size and growth prospects, 2012-2022
3.3. STD diagnostics market dynamics
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. STD diagnostics: Company market share, 2014
3.7. STD diagnostics market PESTEL analysis, 2014
Browse All Healthcare Market Research Related Reports @
http://www.hexareports.com/category/healthcare-market
Chapter 4. STD Diagnostics Types Outlook
4.1. STD diagnostics market share by type, 2014 & 2022
4.2. Chlamydia testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.3. Syphilis testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.4. Gonorrhea testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.5. Herpes Simplex Virus testing estimates and forecasts, 2012 - 2022 (USD Billion)
4.6. Human Papilloma Virus testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.7. Human Immunodeficiency Virus testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.8. Chancroid testing market estimates and forecasts, 2012 - 2022 (USD Billion)
4.9. Other devices market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 5. STD Diagnostics Location of Testing Outlook
5.1. STD diagnostics market share by location of testing, 2014 & 2022
5.2. Laboratory testing market estimates and forecasts, 2012 - 2022 (USD Billion)
5.3. Point of Care (PoC) testing market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 6. STD Diagnostics Testing Devices Outlook
6.1. STD diagnostics market share by testing device, 2014 & 2022
6.2. Laboratory devices market estimates and forecasts, 2012 - 2022 (USD Billion)
6.3. Point of Care (PoC) testing market estimates and forecasts, 2012 - 2022 (USD Billion)
Chapter 7. STD Diagnostics Regional Outlook
7.1. North America
7.2. Europe

Hexa Reports
Market Research Reports and Insightful Company Profiles
7.3. Asia Pacific
7.4. Latin America
7.5. MEA
Chapter 8. Competitive Landscape
8.1. Becton Dickinson and company
8.2. Roche Holdings AG
8.3. Hologic Inc.
8.4. BioMerieux
8.5. Alere Inc.
8.6. Danaher Corporation
8.7. Abbott Laboratories
8.8. Affymetrix
8.9. DiaSorin
8.10. Cepheid Inc.
8.11. Orasure
Browse Full Report @ http://www.hexareports.com/report/std-diagnostics-market-analysis/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/